Advertisement
News
Advertisement

FDA blocks Hospira Symbiq touchscreen-enabled infusion pump imports

Wed, 11/14/2012 - 2:46pm
Mass Device

The FDA prohibits Hospira from importing any new Symbiq infusion pumps systems after the medical device company recalled the devices over a touchscreen issue.

Hospira logo

Infusion pump maker Hospira (NYSE:HSP) found itself in deepening water after the FDA decided to prohibit the company from importing any new lots of its Symbiq touchscreen-enabled infusion pumps.

The pumps, which are imported from the company's manufacturing facility in Costa Rica, underwent a Class I recall late last month over touchscreen issues that the FDA said may result in delayed or inaccurate medication delivery that could injure patients.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading